Candriam SCA’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-96,778
| Closed | -$4.27M | – | 723 |
|
2025
Q1 | $4.27M | Sell |
96,778
-67,237
| -41% | -$2.97M | 0.03% | 364 |
|
2024
Q4 | $5.93M | Sell |
164,015
-681,155
| -81% | -$24.6M | 0.03% | 328 |
|
2024
Q3 | $27.1M | Buy |
845,170
+323,066
| +62% | +$10.4M | 0.16% | 141 |
|
2024
Q2 | $19.7M | Buy |
522,104
+321,476
| +160% | +$12.1M | 0.12% | 171 |
|
2024
Q1 | $9.87M | Sell |
200,628
-75,000
| -27% | -$3.69M | 0.06% | 257 |
|
2023
Q4 | $10.1M | Buy |
275,628
+125,002
| +83% | +$4.56M | 0.07% | 249 |
|
2023
Q3 | $3.48M | Hold |
150,626
| – | – | 0.02% | 358 |
|
2023
Q2 | $3.95M | Buy |
150,626
+139,136
| +1,211% | +$3.65M | 0.03% | 371 |
|
2023
Q1 | $272K | Sell |
11,490
-150,619
| -93% | -$3.57M | ﹤0.01% | 858 |
|
2022
Q4 | $4.22M | Hold |
162,109
| – | – | 0.03% | 419 |
|
2022
Q3 | $4.63M | Hold |
162,109
| – | – | 0.03% | 396 |
|
2022
Q2 | $3.99M | Hold |
162,109
| – | – | 0.03% | 360 |
|
2022
Q1 | $9.15M | Sell |
162,109
-10,447
| -6% | -$590K | 0.06% | 270 |
|
2021
Q4 | $10.7M | Buy |
172,556
+31,722
| +23% | +$1.97M | 0.07% | 255 |
|
2021
Q3 | $8.94M | Hold |
140,834
| – | – | 0.06% | 296 |
|
2021
Q2 | $11.6M | Buy |
140,834
+4,955
| +4% | +$408K | 0.08% | 265 |
|
2021
Q1 | $9.47M | Sell |
135,879
-1
| -0% | -$70 | 0.08% | 258 |
|
2020
Q4 | $9.86M | Buy |
+135,880
| New | +$9.86M | 0.08% | 264 |
|